133 related articles for article (PubMed ID: 35339758)
1. Valproic acid decreases vascular smooth muscle cell proliferation via protein phosphatase 2A-mediated p70 S6 kinase inhibition.
Lee H; Hwang YJ; Park JH; Cho DH
Biochem Biophys Res Commun; 2022 May; 606():94-99. PubMed ID: 35339758
[TBL] [Abstract][Full Text] [Related]
2. Activation of AMPK by Telmisartan Decreases Basal and PDGF-stimulated VSMC Proliferation via Inhibiting the mTOR/p70S6K Signaling Axis.
Hwang YJ; Park JH; Cho DH
J Korean Med Sci; 2020 Sep; 35(35):e289. PubMed ID: 32893519
[TBL] [Abstract][Full Text] [Related]
3. Far-Infrared Irradiation Decreases Proliferation in Basal and PDGF-Stimulated VSMCs Through AMPK-Mediated Inhibition of mTOR/p70S6K Signaling Axis.
Hwang YJ; Park JH; Cho DH
J Korean Med Sci; 2023 Oct; 38(41):e335. PubMed ID: 37873631
[TBL] [Abstract][Full Text] [Related]
4. Chicoric acid prevents PDGF-BB-induced VSMC dedifferentiation, proliferation and migration by suppressing ROS/NFκB/mTOR/P70S6K signaling cascade.
Lu QB; Wan MY; Wang PY; Zhang CX; Xu DY; Liao X; Sun HJ
Redox Biol; 2018 Apr; 14():656-668. PubMed ID: 29175753
[TBL] [Abstract][Full Text] [Related]
5. Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling.
Osman I; Segar L
Biochem Pharmacol; 2016 Feb; 101():54-70. PubMed ID: 26643070
[TBL] [Abstract][Full Text] [Related]
6. Sulforaphane inhibits platelet-derived growth factor-induced vascular smooth muscle cell proliferation by targeting mTOR/p70S6kinase signaling independent of Nrf2 activation.
Shawky NM; Segar L
Pharmacol Res; 2017 May; 119():251-264. PubMed ID: 28212891
[TBL] [Abstract][Full Text] [Related]
7. Ketamine, a Clinically Used Anesthetic, Inhibits Vascular Smooth Muscle Cell Proliferation via PP2A-Activated PI3K/Akt/ERK Inhibition.
Chang Y; Li JY; Jayakumar T; Hung SH; Lee WC; Manubolu M; Sheu JR; Hsu MJ
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186909
[TBL] [Abstract][Full Text] [Related]
8. Zedoarondiol Inhibits Platelet-Derived Growth Factor-Induced Vascular Smooth Muscle Cells Proliferation via Regulating AMP-Activated Protein Kinase Signaling Pathway.
Mao H; Tao T; Song D; Liu M; Wang X; Liu X; Shi D
Cell Physiol Biochem; 2016; 40(6):1506-1520. PubMed ID: 27997894
[TBL] [Abstract][Full Text] [Related]
9. The inhibition of insulin-stimulated proliferation of vascular smooth muscle cells by rosiglitazone is mediated by the Akt-mTOR-P70S6K pathway.
Park S; Lim S; Chang W; Song H; Lee S; Song BW; Kim HJ; Cha MJ; Choi E; Jang Y; Chung N; Cho SY; Hwang KC
Yonsei Med J; 2008 Aug; 49(4):592-600. PubMed ID: 18729301
[TBL] [Abstract][Full Text] [Related]
10. Troglitazone acutely inhibits protein synthesis in endothelial cells via a novel mechanism involving protein phosphatase 2A-dependent p70 S6 kinase inhibition.
Cho DH; Choi YJ; Jo SA; Ryou J; Kim JY; Chung J; Jo I
Am J Physiol Cell Physiol; 2006 Aug; 291(2):C317-26. PubMed ID: 16825603
[TBL] [Abstract][Full Text] [Related]
11. PMC, a potent hydrophilic α-tocopherol derivative, inhibits NF-κB activation via PP2A but not IκBα-dependent signals in vascular smooth muscle cells.
Hsieh CY; Hsiao G; Hsu MJ; Wang YH; Sheu JR
J Cell Mol Med; 2014 Jul; 18(7):1278-89. PubMed ID: 24725826
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells.
Kim TJ; Yun YP
Vascul Pharmacol; 2007 Jan; 46(1):43-51. PubMed ID: 16875883
[TBL] [Abstract][Full Text] [Related]
13. PYK2 signaling is required for PDGF-dependent vascular smooth muscle cell proliferation.
Perez J; Torres RA; Rocic P; Cismowski MJ; Weber DS; Darley-Usmar VM; Lucchesi PA
Am J Physiol Cell Physiol; 2011 Jul; 301(1):C242-51. PubMed ID: 21451101
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II Receptor Type 1 Antagonists Modulate Vascular Smooth Muscle Cell Proliferation and Migration via AMPK/mTOR.
Zhao Y; Shang F; Shi W; Zhang J; Zhang J; Liu X; Li B; Hu X; Wang L
Cardiology; 2019; 143(1):1-10. PubMed ID: 31307032
[TBL] [Abstract][Full Text] [Related]
15. N-Ethylmaleimide inhibits platelet-derived growth factor BB-stimulated Akt phosphorylation via activation of protein phosphatase 2A.
Yellaturu CR; Bhanoori M; Neeli I; Rao GN
J Biol Chem; 2002 Oct; 277(42):40148-55. PubMed ID: 12171932
[TBL] [Abstract][Full Text] [Related]
16. Rapid estrogen receptor signaling mediates estrogen-induced inhibition of vascular smooth muscle cell proliferation.
Ueda K; Lu Q; Baur W; Aronovitz MJ; Karas RH
Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1837-43. PubMed ID: 23744991
[TBL] [Abstract][Full Text] [Related]
17. Serum and glucocorticoid-regulated kinase 1 promotes vascular smooth muscle cell proliferation via regulation of β-catenin dynamics.
Zhong W; Oguljahan B; Xiao Y; Nelson J; Hernandez L; Garcia-Barrio M; Francis SC
Cell Signal; 2014 Dec; 26(12):2765-72. PubMed ID: 25152363
[TBL] [Abstract][Full Text] [Related]
18. p70 Ribosomal S6 kinase is required for airway smooth muscle cell size enlargement but not increased contractile protein expression.
Deng H; Hershenson MB; Lei J; Bitar KN; Fingar DC; Solway J; Bentley JK
Am J Respir Cell Mol Biol; 2010 Jun; 42(6):744-52. PubMed ID: 19648476
[TBL] [Abstract][Full Text] [Related]
19. 17Beta-estradiol attenuates PDGF signaling in vascular smooth muscle cells at the postreceptor level.
Kappert K; Caglayan E; Huntgeburth M; Bäumer AT; Sparwel J; Uebel M; Rosenkranz S
Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H538-46. PubMed ID: 16227346
[TBL] [Abstract][Full Text] [Related]
20. mTOR regulates vascular smooth muscle cell differentiation from human bone marrow-derived mesenchymal progenitors.
Hegner B; Lange M; Kusch A; Essin K; Sezer O; Schulze-Lohoff E; Luft FC; Gollasch M; Dragun D
Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):232-8. PubMed ID: 19074484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
